Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom.
MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom.
PLoS Pathog. 2021 Mar 2;17(3):e1009301. doi: 10.1371/journal.ppat.1009301. eCollection 2021 Mar.
The mitochondrial electron transport chain (mETC) and F1Fo-ATP synthase are of central importance for energy and metabolism in eukaryotic cells. The Apicomplexa, important pathogens of humans causing diseases such as toxoplasmosis and malaria, depend on their mETC in every known stage of their complicated life cycles. Here, using a complexome profiling proteomic approach, we have characterised the Toxoplasma mETC complexes and F1Fo-ATP synthase. We identified and assigned 60 proteins to complexes II, IV and F1Fo-ATP synthase of Toxoplasma, of which 16 have not been identified previously. Notably, our complexome profile elucidates the composition of the Toxoplasma complex III, the target of clinically used drugs such as atovaquone. We identified two new homologous subunits and two new parasite-specific subunits, one of which is broadly conserved in myzozoans. We demonstrate all four proteins are essential for complex III stability and parasite growth, and show their depletion leads to decreased mitochondrial potential, supporting their assignment as complex III subunits. Our study highlights the divergent subunit composition of the apicomplexan mETC and F1Fo-ATP synthase complexes and sets the stage for future structural and drug discovery studies.
线粒体电子传递链(mETC)和 F1Fo-ATP 合酶对真核细胞的能量和代谢至关重要。顶复门生物是重要的人类病原体,可引起弓形体病和疟疾等疾病,在其复杂生命周期的每个已知阶段都依赖其 mETC。在这里,我们使用复杂蛋白质组学方法对弓形虫的 mETC 复合物和 F1Fo-ATP 合酶进行了表征。我们鉴定并分配了 60 种蛋白质到 Toxoplasma 的复合物 II、IV 和 F1Fo-ATP 合酶中,其中 16 种以前未被鉴定过。值得注意的是,我们的复杂蛋白质组图谱阐明了 Toxoplasma 复合物 III 的组成,复合物 III 是临床上使用的阿托伐醌等药物的靶标。我们鉴定了两个新的同源亚基和两个新的寄生虫特异性亚基,其中一个在 Myzozoans 中广泛保守。我们证明这四个蛋白对于复合物 III 的稳定性和寄生虫的生长都是必不可少的,并且它们的耗竭导致线粒体潜能降低,这支持了它们作为复合物 III 亚基的分配。我们的研究强调了顶复门生物 mETC 和 F1Fo-ATP 合酶复合物的不同亚基组成,并为未来的结构和药物发现研究奠定了基础。